Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 311, Issue 6, 2016, Pages R1192-R1199

  Cornelius, Denise C ^a   Amaral, Lorena M ^a   Wallace, Kedra ^a   Campbell, Nathan ^a   Thomas, Alexia J ^a   Scott, Jeremy ^a   Herse, Florian ^b   Wallukat, Gerd ^b   Dechend, Ralf ^b,c   LaMarca, Babbette ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Helios Klinikum   (Germany)

Author keywords

Hypertension; IL 17; Intrauterine growth restriction; Oxidative stress; Pregnancy; T helper 17

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AUTOANTIBODY; INTERLEUKIN 17; INTERLEUKIN 6; LOSARTAN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TEMPOL; CYTOKINE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; CAROTID ARTERY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS WEIGHT; FLOW CYTOMETRY; HYPERTENSION; IN VITRO STUDY; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE PRESSURE; KIDNEY CORTEX; LYMPHOCYTE SUBPOPULATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PLACENTA; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RAT; REDUCED UTERINE PERFUSION PRESSURE; SPLEEN; TH17 CELL; UTERINE ARTERY; ANIMAL; AUTOIMMUNITY; BLOOD PRESSURE; HUMAN; IMMUNOLOGY; PATHOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALS; AUTOIMMUNITY; BLOOD PRESSURE; CYTOKINES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TH17 CELLS; UTERINE ARTERY;

EID: 85007188912     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00117.2016     Document Type: Article

References (30)

1. Cornelius DC, Hogg JP, Scott J, Wallace K, Herse F, Moseley J, Wallukat G, Dechend R, LaMarca B. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62: 1068-1073, 2013. doi:10.1161/HYPERTENSIONAHA.113.01514.
2. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 93: 75-81, 2012. doi:10.1016/j.jri.2012.01.006.
3. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101: 2382-2387, 2000. doi:10.1161/01.CIR.101.20.2382.
4. Dechend R, Homuth V, Wallukat G, Müller DN, Krause M, Dudenhausen J, Haller H, Luft FC. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig 13: 79-86, 2006. doi:10.1016/j.jsgi.2005.11.006.
5. Dechend R, Müller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev 4: 61-65, 2005. doi:10.1016/j.autrev.2004.07.002.
6. Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, Mosely J, Martin JN Jr, Dechend R, LaMarca B. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol 303: R353-R358, 2012. doi:10.1152/ajpregu.00051.2012.
7. George EM, Granger JP. Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol 5: 557-566, 2010. doi:10.1586/eog.10.45.
8. Gilbert J, Dukes M, LaMarca B, Cockrell K, Babcock S, Granger J. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens 20: 686-691, 2007. doi:10.1016/j.amjhyper.2006.12.016.
9. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 122: 383-392, 2006.
10. LaMarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol 62: 105-120, 2010.
11. LaMarca B, Brewer J, Wallace K. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Interferon Cytokine Mediat Res 2011: 59-64, 2011. doi: 10.2147/IJICMR.S16320.
12. LaMarca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, Wallukat G, Wenzel K, Cockrell K, Martin JN Jr, Ryan MJ, Dechend R. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54: 905-909, 2009. doi:10.1161/HYPERTENSIONAHA.109.137935.
13. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol 94: 247-257, 2013. doi:10.1189/jlb.1112603.
14. Lee SK, Kim JY, Lee M, Gilman-Sachs A, Kwak-Kim J. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 67: 311-318, 2012. doi:10.1111/j.1600-0897.2012.01116.x.
15. Lindheimer MD, Romero R. Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia. Hypertension 50: 35-36, 2007. doi:10.1161/HYPERTENSIONAHA.107.089045.
16. Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A, Wallukat G, Herse F, Wenzel K, Martin JN Jr, Dechend R, Lamarca B. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol 302: R1197-R1201, 2012. doi:10.1152/ajpregu.00623.2011.
17. Parrish MR, Murphy SR, Rutland S, Wallace K, Wenzel K, Wallukat G, Keiser S, Ray LF, Dechend R, Martin JN, Granger JP, LaMarca B. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens 23: 911-916, 2010. doi:10.1038/ajh.2010.70.
18. Parrish MR, Ryan MJ, Glover P, Brewer J, Ray L, Dechend R, Martin JN Jr, Lamarca BB. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend Med 8: 184-188, 2011. doi:10.1016/j.genm.2011.04.003.
19. Parrish MR, Wallace K, Tam Tam KB, Herse F, Weimer A, Wenzel K, Wallukat G, Ray LF, Arany M, Cockrell K, Martin JN, Dechend R, LaMarca B. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens 24: 835-840, 2011. doi:10.1038/ajh.2011.62.
20. Prins JR, Gomez-Lopez N, Robertson SA. Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol 95: 1-14, 2012. doi:10.1016/j.jri.2012.05.004.
21. 1-AAs cause hypertension in response to placental ischemia. Am J Obstet Gynecol 204: S100, 2011.
22. Roberts JM, Lain KY. Recent Insights into the pathogenesis of preeclampsia. Placenta 23: 359-372, 2002. doi:10.1053/plac.2002.0819.
23. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63: 601-610, 2010. doi:10.1111/j.1600-0897.2010.00852.x.
24. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 183: 7023-7030, 2009. doi:10.4049/jimmunol.0901154.
25. Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 21: 1152-1156, 2008. doi:10.1038/ajh.2008.239.
26. Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm 2012: 967629, 2012. doi:10.1155/2012/967629.
27. Toldi G, Rigó J Jr, Stenczer B, Vásárhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in preeclampsia. Am J Reprod Immunol 66: 223-229, 2011. doi:10.1111/j.1600-0897.2011.00987.x.
28. Wallace K, Richards S, Dhillon P, Weimer A, Edholm ES, Bengten E, Wilson M, Martin JN Jr, LaMarca B. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57: 949-955, 2011. doi:10.1161/HYPERTENSIONAHA.110.168344.
29. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103: 945-952, 1999. doi:10.1172/JCI4106.
30. Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol 32: 603-611, 2011. doi:10.1016/j.it.2011.08.003.